Itolizumab

  • July 13, 2020
  • Posted by: OptimizeIAS Team
  • Category: DPN Topics
1 Comment

Subject: Science and tech

Context:

Biocon has gotten approval of DGCI nod to market Itolizumab for Covid treatment

Concept:

  • It is a drug used to cure skin ailment psoriasis
  • It is approved for restricted emergency use for the treatment of cytokine’ release syndrome in moderate to severe acute respiratory distress syndrome patients due to Covid-19
Itolizumab Science and tech

Comments are closed.